An exploratory phase II study of Eribulin re-challenge after short term therapy of 5-fuluorouracil for HER2-negative, advanced or recurrent breast cancer
Titel:
An exploratory phase II study of Eribulin re-challenge after short term therapy of 5-fuluorouracil for HER2-negative, advanced or recurrent breast cancer
Auteur:
Takashima, T. Nishimura, S. Kawajiri, H. Mizuyama, Y. Nishimori, T. Yamagata, S. Tokunaga, S. Tezuka, K. Tei, S. Sunami, T. Ikeda, K. Ogawa, Y. Kashiwagi, S. Noda, S. Onoda, N. Ishikawa, T. Kudoh, S. Takada, M. Hirakawa, K. Ohira, M.